{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:05:27Z","timestamp":1648526727376},"reference-count":16,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p>PURPOSE: To compare the therapeutic effect of rimonabant, a new drug which is a selective antagonist of CB1 receptors, with the sibutramine. METHODS: It is an experimental clinical trial, prospective, placebo controlled. Our test was performed in 38 rats, adults females with a hyper caloric diet. We collected their blood 3 times and weighted them once a week. We divided the rats in 3 groups: Rimonabant, Sibutramine and Control. Statistic analysis has been made through ANOVA test, Tukey test and t Student test. RESULTS: The Rimonabant group demonstrated a significant reduction of the weight increase in rats. The Sibutramine group showed a significant reduction on blood glycemia compared to Rimonabant group and Control group. CONCLUSIONS: Rimonabant showed to be more effective than Sibutramine by decreasing weight gain. Sibutramine has been more effective than Rimonabant and Control groups by decreasing the blood glycemia.<\/jats:p>","DOI":"10.1590\/s0102-86502009000600006","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T08:38:53Z","timestamp":1260434333000},"page":"454-459","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of rimonabant and sibutramine treatment effects on food compulsion in rats"],"prefix":"10.1590","volume":"24","author":[{"given":"Hon\u00f3rio Sampaio","family":"Menezes","sequence":"first","affiliation":[{"name":"Cardiology University Foundation,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f4nica","family":"Ciulla","sequence":"additional","affiliation":[{"name":"ULBRA,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Sampaio","family":"Camargo","sequence":"additional","affiliation":[{"name":"ULBRA,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora Albrecht","family":"Correa","sequence":"additional","affiliation":[{"name":"ULBRA,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Medina Costa de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"ULBRA,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Estudo da compuls\u00e3o alimentar peri\u00f3dica em pacientes que procuram tratamento m\u00e9dico para emagrecer","author":"Coutinho W","year":"2000"},{"key":"ref2","first-page":"1","article-title":"Editorial","author":"Silveira TR","year":"2008","journal-title":"Bol Cient AMRIGS"},{"key":"ref3","series-title":"Psiquiatria, diagn\u00f3stico e tratamento","author":"Flaherty D","year":"1995"},{"key":"ref4","first-page":"03","article-title":"Tratamento de transtornos alimentares em hospital-dia","volume":"11","author":"Salzano FT","year":"2000","journal-title":"Boletim de Transtornos Afetivos e Alimentares (BOTA)"},{"key":"ref5","first-page":"1","article-title":"A epidemia chegou","volume":"2","author":"Friedman R","year":"2008","journal-title":"Bol Cient AMRIGS"},{"issue":"9600","key":"ref6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen R","year":"2007","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref7","first-page":"3","article-title":"Tratamento farmacol\u00f3gico da obesidade","volume":"2","author":"Repetto G","year":"2008","journal-title":"Bol Cient AMRIGS"},{"key":"ref8","series-title":"Tratamento psiqui\u00e1trico da obesidade","author":"Ballone GJ"},{"key":"ref9","series-title":"S\u00edndrome metab\u00f3lica e depress\u00e3o: Comorbidades depress\u00e3o e s\u00edndrome metab\u00f3lica UNIFESP","author":"Zanella MT","year":"2008"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1590\/S0004-27302006000200025","article-title":"O Sistema endocanabin\u00f3ide: novo paradigma no tratamento da s\u00edndrome metab\u00f3lica","volume":"50","author":"Mattos AG","year":"2006","journal-title":"Arq Bras Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1210\/en.2007-1515","article-title":"Increased energy expendure contributes more to the body weight reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats","volume":"149","author":"Herling AW","year":"2008","journal-title":"Endocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","article-title":"Long term pharmacotherapy for obesity and overweight: updated meta-analysis","volume":"335","author":"Rucker D","year":"2007","journal-title":"BMJ","ISSN":"http:\/\/id.crossref.org\/issn\/0959-8138","issn-type":"print"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/vhrm.2007.3.2.181","article-title":"Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data","volume":"3","author":"Bronander A","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00002018-200326140-00004","article-title":"A benefit-risk assessment of sibutramine in the management of obesity","volume":"26","author":"Nisoli E","year":"2003","journal-title":"Drug Safety","ISSN":"http:\/\/id.crossref.org\/issn\/0114-5916","issn-type":"print"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.bjp.0706807","article-title":"Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats","volume":"148","author":"Fisas A","year":"2006","journal-title":"Br J Pharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1188","issn-type":"print"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-002-1384-8","article-title":"Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa\/fa ) compared to lean Zucker rats","volume":"167","author":"Vickers SP","year":"2003","journal-title":"Psychopharmacology (Berl)","ISSN":"http:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"}],"container-title":["Acta Cirurgica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/acb\/v24n6\/06.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T12:51:52Z","timestamp":1495803112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502009000600006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0102-86502009000600006"],"URL":"https:\/\/doi.org\/10.1590\/s0102-86502009000600006","relation":{},"ISSN":["0102-8650"],"issn-type":[{"value":"0102-8650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}